Martina Cantarella

Pisa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study.

Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study.

Journal: Journal of neuro-oncology

Published: November 28, 2025

Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership?

Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership?

Journal: Journal of clinical medicine

Published: January 23, 2024

IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients.

IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients.

Journal: BMC cancer

Published: November 02, 2023

Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.

Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.

Journal: Genes

Published: April 03, 2022

Stereotactic radiotherapy for oligometastases in the lymph nodes.

Stereotactic radiotherapy for oligometastases in the lymph nodes.

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Published: September 13, 2021

Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy.

Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy.

Journal: La Radiologia medica

Published: August 26, 2021

Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma.

Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma.

Journal: La Radiologia medica

Published: July 20, 2021

Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.

Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.

Journal: Acta neurologica Belgica

Published: March 28, 2021

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?

Journal: Future oncology (London, England)

Published: April 13, 2019

[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer.

[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 01, 2019

Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration.

Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration.

Journal: Anticancer research

Published: July 05, 2018

Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.

Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.

Journal: American journal of clinical oncology

Published: May 22, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026